Dilawer Farazi Returns to Loomis Sayles as Co-Head and Portfolio Manager on the Emerging Markets Debt Team November 17, 2025 Loomis, Sayles & Company is pleased to announce that Dilawer Farazi, ACA, has rejoined the firm as Co-Head and Portfolio Manager of the Emerging Markets Debt (EMD) Team. Dilawer becomes the firm’s first London-based portfolio manager. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117681347/en/ Dilawer brings over two decades of experience in [...]
Duravant Announces Retirement of CEO Mike Kachmer, Names Jill Evanko Successor November 17, 2025 Mike Kachmer to retire following a distinguished 43-year career, including nearly 12 years as Chairman & CEO of Duravant Jill Evanko to succeed Mr. Kachmer as Duravant’s Chief Executive Officer
Broken String Biosciences Announces New Leadership to Drive Commercialization of INDUCE-seq® Platform for Gene Editing On- and Off-target Characterization November 17, 2025 Broken String Biosciences (“Broken String”), a leader in advancing gene editing safety, today announced the appointment of new leadership to drive the commercialization of its INDUCE-seq® platform, now available to cell and gene therapy developers worldwide. To drive the company’s commercial expansion, Terry Pizzie has been appointed as CEO, bringing extensive experience from leading and [...]
MSCI Announces Baer Pettit to Retire as President November 17, 2025 Additional senior leadership changes will drive growth in new client segments and products
Bureau Veritas appoints Santiago Arias Duval as Executive Vice-President for the Americas region November 17, 2025 Bureau Veritas, a global leader in Testing, Inspection and Certification (TIC), is pleased to announce the appointment of Santiago Arias Duval, effective November 17th, 2025, as Executive Vice-President, Americas. This appointment is in line with Bureau Veritas’ new operating model effective since September 1st, 2025. This press release features multimedia. View the full release here: [...]
Burt Y. Chao joins Nintex as Chief Financial Officer November 12, 2025 Nintex, the global leader in agentic business orchestration, today announced the appointment of Burt Y. Chao as Chief Financial Officer. Chao brings more than 20 years of experience leading financial strategy, operational excellence, and transformation across high-growth technology companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112862459/en/ Chao has held senior finance [...]
Huge Appoints Josh Campo as CEO to Lead Independent Firm’s Next Chapter of Growth and Innovation November 12, 2025 Campo Joins Leading Design and Technology Company Focused on Building Digital Products and Intelligent Experiences
SOFR Academy Appoints R. Martin “Marty” Chávez as Senior Advisor November 12, 2025 SOFR Academy, Inc., a leading financial engineering firm, today announced the appointment of R. Martin “Marty” Chávez as Senior Advisor. Widely regarded as one of the most influential figures at the intersection of finance, technology, and data science, Mr. Chávez brings decades of leadership experience shaping modern financial markets and innovation ecosystems. He is a [...]
Alentis Strengthens Management Team with Key Appointments November 12, 2025 Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company developing first-in-class therapies targeting claudin-1 for a range of fibrosis and oncology indications, today announced the appointment of Bryan Yoon as General Counsel and Chief Administrative Officer, and Aditya Venugopal as Chief Business Officer. Mr. Yoon and Dr. Venugopal are joining Alentis’ executive leadership team. “We are expanding [...]
Exstent Appoints Matt Thompson as CEO to Drive Global Growth in Personalised Aortic Support November 12, 2025 Exstent, a UK-based medical device company, developing personalised external aortic support to preserve the native aorta, today announced the appointment of Matt Thompson as Chief Executive Officer to lead its next phase of global growth. Matt brings more than two decades of combined clinical and commercial leadership to Exstent. He previously held leadership roles including [...]
